After hormone replacement therapy (HRT), the level of estrogen may improve; however, it is still difficult to recover the level of FSH to the pre-menopausal range27, which probably explains why estrogen replacement does not fully protect postmenopausal women from developing abnormal glucose tolerance. This evidence concerns the gene BRD2 and abnormal glucose tolerance.